Xoma Says On December 3, Co, As Successor-In-Interest Of Xoma Ireland Ltd, Pfizer Entered into Settlement, Amended License Agreement; Xoma Granted Rights to Patented Bacterial Cell Expression Technology For Upfront Payment By Pfizer Of $3.8M